Wells Fargo & Company Opgen Inc Transaction History

Wells Fargo & Company

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.12 - $62.0 $5 - $2,790	45 Added 13.98%	367 $0
Q3 2022 Nov 14, 2022	BUY	$0.39 - $78.8 $3 - $709	9 Added 2.88%	322 $0
Q2 2022 Aug 12, 2022	BUY	$0.32 - $0.79 $8 - $20	26 Added 9.06%	313 $0
Q1 2022 May 16, 2022	SELL	$0.72 - $1.11 $146 - $225	-203 Reduced 41.43%	287 $0
Q4 2021 Feb 14, 2022	BUY	$1.0 - $2.94 $4 - $11	4 Added 0.82%	490 $0
Q3 2021 Nov 15, 2021	SELL	$2.18 - $3.58 $23 - $39	-11 Reduced 2.21%	486 $2,000
Q2 2021 Aug 16, 2021	BUY	$1.95 - $2.8 $226 - $324	116 Added 30.45%	497 $2,000
Q1 2021 May 13, 2021	SELL	$1.8 - $3.55 $1,800 - $3,550	-1,000 Reduced 72.41%	381 $1,000
Q4 2020 Feb 09, 2021	BUY	$1.7 - $2.47 $40 - $59	24 Added 1.77%	1,381 $3,000
Q3 2020 Nov 05, 2020	BUY	$1.98 - $3.37 $2,013 - $3,427	1,017 Added 299.12%	1,357 $3,000
Q2 2020 Aug 13, 2020	BUY	$1.88 - $2.59 $573 - $789	305 Added 871.43%	340 $1,000
Q1 2020 May 14, 2020	BUY	$1.14 - $4.04 $39 - $141	35 New	35 $0

Ticker OPGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,698,500
Market Cap $38.7M
Description
OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants o...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.